Table 4.
Prevalence and scores of stress and insomnia symptoms among the patients stratified by socio-demographics and clinical characteristics
| Variables | Stress symptoms (DASS-21 stress score) | Insomnia symptoms (ISI score) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Prevalence | Median | IQR | P-value† | Prevalence | Median | IQR | P-value† | |||||
| n | % | n | % | |||||||||
| Total 223 patients | 133 | 59.6 | 10.0 | 5.0 | 14.0 | – | 127 | 57.0 | 12.0 | 4.0 | 18.0 | – |
| Age [year]: | 0.87 | 0.30 | ||||||||||
| 18–30 | 47 | 58.8 | 10.0 | 5.0 | 14.0 | 40 | 50.0 | 9.5 | 2.0 | 18.5 | ||
| 31–40 | 47 | 62.7 | 10.0 | 4.0 | 17.0 | 47 | 62.7 | 13.0 | 7.0 | 19.0 | ||
| > 40 | 34 | 55.7 | 9.0 | 5.0 | 13.0 | 36 | 59.0 | 12.0 | 4.0 | 17.0 | ||
| Gender | 0.02 | 0.30 | ||||||||||
| Males | 67 | 53.2 | 8.0 | 4.0 | 14.0 | 70 | 55.6 | 11.0 | 3.0 | 17.0 | ||
| Females | 64 | 68.8 | 12.0 | 6.0 | 16.0 | 55 | 59.1 | 13.0 | 6.0 | 20.0 | ||
| Psoriasis duration [year]: | 0.70 | 0.55 | ||||||||||
| < 6 | 30 | 56.6 | 9.0 | 6.0 | 16.0 | 32 | 60.4 | 12.0 | 4.0 | 20.0 | ||
| 6–15 | 41 | 54.7 | 9.0 | 5.0 | 14.0 | 41 | 54.7 | 11.0 | 3.0 | 16.0 | ||
| > 15 | 53 | 66.3 | 10.5 | 4.0 | 15.0 | 45 | 56.3 | 12.0 | 4.5 | 18.0 | ||
| Psoriasis severity (sa-SPI-s): | 0.04 | 0.06 | ||||||||||
| Mild (< 10) | 67 | 54.9 | 9.0 | 4.0 | 13.0 | 65 | 53.3 | 10.0 | 3.0 | 17.0 | ||
| Moderate (10–20) | 33 | 60.0 | 10.0 | 5.0 | 14.0 | 32 | 58.2 | 12.0 | 7.0 | 16.0 | ||
| Severe (> 20) | 27 | 77.1 | 13.0 | 8.0 | 18.0 | 24 | 68.6 | 17.0 | 5.0 | 22.0 | ||
| Impact of psoriasis on daily life (sa-SPI-p): | 0.0001 | 0.0001 | ||||||||||
| < 4 | 25 | 39.1 | 7.0 | 3.0 | 11.0 | 27 | 42.2 | 7.0 | 2.0 | 13.0 | ||
| 4–7 | 40 | 58.0 | 9.0 | 4.0 | 14.0 | 39 | 56.5 | 11.0 | 5.0 | 16.0 | ||
| > 7 | 65 | 78.3 | 13.0 | 8.0 | 18.0 | 58 | 69.9 | 17.0 | 8.0 | 22.0 | ||
| Education level: | 0.43 | 0.43 | ||||||||||
| Primary | 22 | 62.9 | 11.0 | 5.0 | 15.0 | 15 | 57.1 | 8.0 | 2.0 | 17.0 | ||
| Secondary | 33 | 64.7 | 11.0 | 5.0 | 16.0 | 33 | 35.3 | 12.0 | 6.0 | 18.0 | ||
| Higher | 75 | 57.3 | 9.0 | 5.0 | 14.0 | 76 | 42.0 | 12.0 | 5.0 | 18.0 | ||
DASS-21 – Depression Anxiety Stress Scale, ISI – Insomnia Severity Index, sa-SPI-s – self-assessed Simplified Psoriasis Index-severity scale, sa-SPI-P– self-assessed Simplified Psoriasis index-psychosocial impact.
†
The Kmskal-WalUs testbyranks or WUcoxon signed-rank test.